Secondary cytoreduction in ovarian cancer: pro or con?
During a symposium in the therapy for ovarian cancer as a prelude to the Gynecologic Oncology Group meeting in July 1992, the relative merits of secondary cytoreductive surgery were debated. The author presented part of the con argument. The content of that position is presented.
Potter
M E
ME
Madigan Army Medical Center, Tacoma, Washington 98431.
D002277:Carcinoma / Q000601:surgery*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000601:surgery*; D012086:Reoperation; D016019:Survival Analysis